Expanding Access to
Hyperbaric Oxygen Therapy

A physician-integrated hyperbaric system
designed for outpatient clinical environments.

Request a Physician Briefing Explore the Investment Opportunity

The Problem

Access to Hyperbaric Therapy Remains Limited

Hyperbaric oxygen therapy (HBOT) is clinically established, yet access remains constrained by infrastructure, cost, and hospital-based deployment models.

  • Most systems are designed for hospital settings
  • Limited availability in outpatient environments
  • Barriers to physician-level integration

The Solution

Designed for the Physician Office

RxAir360 is a vertical monoplace hyperbaric system engineered specifically for outpatient clinical use.

  • Designed for standard 100–120 sq ft exam rooms
  • Supports physician-led clinical workflows
  • Enables integration without hospital-scale infrastructure

Product Overview

A Purpose-Built Clinical System

RxAir360 is not adapted from legacy systems — it is designed from the ground up for physician-office deployment.

  • Vertical, seated monoplace configuration
  • Steel construction with acrylic viewports
  • Built for outpatient clinical environments

Safety & Compliance

Engineered Within Established Safety Frameworks

The system is designed in alignment with recognized industry standards governing hyperbaric chambers in North America.

  • Designed to meet ASME PVHO-1 standards
  • Built in alignment with NFPA 99 requirements
  • Incorporates manual safety redundancies independent of software

Manufactured using aerospace-grade engineering processes, with precision fabrication and quality control methodologies.

Market Opportunity

An Underserved Clinical Market

There are currently under 1,400 hyperbaric treatment facilities in the United States, with limited access at the physician-office level.

  • Significant opportunity for outpatient expansion
  • Increasing awareness of HBOT applications
  • Gap between demand and accessibility

Business Model

Flexible Deployment for Clinical Practices

RxAir360 supports multiple pathways for adoption:

  • Direct system sales
  • Leasing through RxAir Capital Solutions
  • Integration into existing physician practices

Current Status

Advancing Through Regulatory and Validation Milestones

  • FDA 510(k) clearance process in progress
  • Electrical and safety testing nearing completion
  • Documentation and validation nearing completion
  • Market rollout strategy beginning with Texas, followed by Florida

Vision

Building Toward Scalable Clinical Access

RxAir360 is focused on expanding access to hyperbaric therapy through physician-integrated deployment and scalable clinical infrastructure.

Future initiatives include:

  • Enhanced operational support tools
  • Data-driven system monitoring
  • Continued expansion into outpatient care environments

Start the Conversation

Whether you are a physician, investor, or strategic partner, we welcome the opportunity to connect.

Request a Physician Briefing Investor Inquiries Partnership Discussions

Regulatory Note: The RxAir360 hyperbaric chamber is currently pending FDA 510(k) clearance and is not approved for medical use or commercial sale. This page is for informational purposes only and does not constitute medical advice or an offer to sell securities.